Loading...

Israel Chemicals

NYSE:ICL
Snowflake Description

Outstanding track record and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ICL
NYSE
₪25B
Market Cap
  1. Home
  2. US
  3. Materials
Company description

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. The last earnings update was 51 days ago. More info.


Add to Portfolio Compare Print
ICL Share Price and Events
7 Day Returns
2.6%
NYSE:ICL
0.8%
US Chemicals
0.2%
US Market
1 Year Returns
23.1%
NYSE:ICL
-6.8%
US Chemicals
6.3%
US Market
ICL Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Israel Chemicals (ICL) 2.6% 5.2% -5.5% 23.1% 10% -37.1%
US Chemicals 0.8% -2.4% 0.4% -6.8% 20.6% 16.3%
US Market 0.2% 2.1% 8.5% 6.3% 37.9% 45.7%
1 Year Return vs Industry and Market
  • ICL outperformed the Chemicals industry which returned -6.8% over the past year.
  • ICL outperformed the Market in United States of America which returned 6.3% over the past year.
Price Volatility
ICL
Industry
5yr Volatility vs Market

ICL Value

 Is Israel Chemicals undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Israel Chemicals to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Israel Chemicals.

NYSE:ICL Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 6 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 9.4%
Perpetual Growth Rate 10-Year US Government Bond Rate 2.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NYSE:ICL
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 2.7%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.93
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.927 (1 + (1- 23%) (34.84%))
1.118
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.12
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.73% + (1.118 * 5.96%)
9.39%

Discounted Cash Flow Calculation for NYSE:ICL using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Israel Chemicals is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

NYSE:ICL DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 9.39%)
2019 244.00 Analyst x2 223.05
2020 229.50 Analyst x2 191.79
2021 134.00 Analyst x1 102.37
2022 85.78 Est @ -35.99% 59.90
2023 64.87 Est @ -24.37% 41.42
2024 54.34 Est @ -16.24% 31.71
2025 48.60 Est @ -10.55% 25.93
2026 45.41 Est @ -6.57% 22.15
2027 43.70 Est @ -3.78% 19.48
2028 42.90 Est @ -1.82% 17.48
Present value of next 10 years cash flows $735.29
NYSE:ICL DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $42.90 × (1 + 2.73%) ÷ (9.39% – 2.73%)
$661.67
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $661.67 ÷ (1 + 9.39%)10
$269.68
NYSE:ICL Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $735.29 + $269.68
$1,004.96
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,004.96 / 1,280.30
$2.82
NYSE:ICL Discount to Share Price
Calculation Result
Exchange Rate USD/ILS
(Reporting currency to currency of TASE:ICL)
3.595
Value per Share
(ILS)
= Value per Share in USD x Exchange Rate (USD/ILS)
= $0.78 x 3.595
₪2.82
Non-primary Listing Adjustment Factor 1 share in NYSE:ICL represents 0.2786x of TASE:ICL
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.2786x
Value per Share
(Listing Adjusted, USD)
= Value per Share (ILS) x Listing Adjustment Factor
= ₪ 2.82 x 0.2786
$0.79
Value per share (USD) From above. $0.79
Current discount Discount to share price of $5.48
= -1 x ($5.48 - $0.79) / $0.79
-597.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Israel Chemicals is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Israel Chemicals's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Israel Chemicals's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NYSE:ICL PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $0.97
TASE:ICL Share Price ** TASE (2019-04-18) in ILS ₪19.67
TASE:ICL Share Price converted to USD reporting currency Exchange rate (ILS/ USD) 0.278 $5.47
United States of America Chemicals Industry PE Ratio Median Figure of 66 Publicly-Listed Chemicals Companies 19.07x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Israel Chemicals.

NYSE:ICL PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TASE:ICL Share Price ÷ EPS (both in USD)

= 5.47 ÷ 0.97

5.64x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Israel Chemicals is good value based on earnings compared to the US Chemicals industry average.
  • Israel Chemicals is good value based on earnings compared to the United States of America market.
Price based on expected Growth
Does Israel Chemicals's expected growth come at a high price?
Raw Data
NYSE:ICL PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 5.64x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts
-15.4%per year
United States of America Chemicals Industry PEG Ratio Median Figure of 46 Publicly-Listed Chemicals Companies 1.56x
United States of America Market PEG Ratio Median Figure of 2,109 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

NYSE:ICL PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 5.64x ÷ -15.4%

-0.37x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Israel Chemicals earnings are not expected to grow next year, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Israel Chemicals's assets?
Raw Data
NYSE:ICL PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $2.95
TASE:ICL Share Price * TASE (2019-04-18) in ILS ₪19.67
TASE:ICL Share Price converted to USD reporting currency Exchange rate (ILS/ USD) 0.278 $5.47
United States of America Chemicals Industry PB Ratio Median Figure of 91 Publicly-Listed Chemicals Companies 2.29x
United States of America Market PB Ratio Median Figure of 5,178 Publicly-Listed Companies 1.91x
NYSE:ICL PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TASE:ICL Share Price ÷ Book Value per Share (both in USD)

= 5.47 ÷ 2.95

1.85x

* Primary Listing of Israel Chemicals.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Israel Chemicals is good value based on assets compared to the US Chemicals industry average.
X
Value checks
We assess Israel Chemicals's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Israel Chemicals has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

ICL Future Performance

 How is Israel Chemicals expected to perform in the next 1 to 3 years based on estimates from 6 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
-15.4%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Israel Chemicals expected to grow at an attractive rate?
  • Israel Chemicals's earnings are expected to decrease over the next 1-3 years, this is below the low risk savings rate of 2.7%.
Growth vs Market Checks
  • Israel Chemicals's earnings are expected to decrease over the next 1-3 years, this is below the United States of America market average.
  • Israel Chemicals's revenue growth is positive but not above the United States of America market average.
Annual Growth Rates Comparison
Raw Data
NYSE:ICL Future Growth Rates Data Sources
Data Point Source Value (per year)
NYSE:ICL Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 6 Analysts -15.4%
NYSE:ICL Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 6 Analysts 4.1%
United States of America Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 12.2%
United States of America Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 2.2%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NYSE:ICL Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NYSE:ICL Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2023-12-31 7,049 576 1
2022-12-31 6,565 506 1
2021-12-31 6,076 741 522 3
2020-12-31 5,869 884 534 6
2019-12-31 5,611 877 465 6
NYSE:ICL Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 5,556 620 1,240
2018-09-30 5,507 673 1,313
2018-06-30 5,576 653 1,268
2018-03-31 5,527 688 1,224
2017-12-31 5,418 847 364
2017-09-30 5,395 827 241
2017-06-30 5,338 900 -183
2017-03-31 5,393 939 -120
2016-12-31 5,363 966 -122
2016-09-30 5,452 767 -58
2016-06-30 5,448 642 403
2016-03-31 5,267 729 358

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Israel Chemicals's earnings are expected to decrease over the next 1-3 years, this is not considered high growth.
  • Israel Chemicals's revenue is expected to grow by 4.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NYSE:ICL Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below

All data from Israel Chemicals Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:ICL Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2023-12-31 0.45 0.45 0.45 1.00
2022-12-31 0.40 0.40 0.40 1.00
2021-12-31 0.41 0.49 0.33 2.00
2020-12-31 0.38 0.45 0.31 2.00
2019-12-31 0.34 0.37 0.30 2.00
NYSE:ICL Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 0.97
2018-09-30 1.03
2018-06-30 0.99
2018-03-31 0.96
2017-12-31 0.29
2017-09-30 0.19
2017-06-30 -0.14
2017-03-31 -0.09
2016-12-31 -0.10
2016-09-30 -0.05
2016-06-30 0.32
2016-03-31 0.28

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Israel Chemicals is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Israel Chemicals's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Israel Chemicals has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

ICL Past Performance

  How has Israel Chemicals performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Israel Chemicals's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Israel Chemicals's year on year earnings growth rate has been positive over the past 5 years.
  • Israel Chemicals's 1-year earnings growth exceeds its 5-year average (240.7% vs 12.6%)
  • Israel Chemicals's earnings growth has exceeded the US Chemicals industry average in the past year (240.7% vs 23.1%).
Earnings and Revenue History
Israel Chemicals's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Israel Chemicals Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NYSE:ICL Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 5,556.00 1,240.00 1,048.00 55.00
2018-09-30 5,507.00 1,313.00 1,080.00 57.00
2018-06-30 5,576.00 1,268.00 1,080.00 56.00
2018-03-31 5,527.00 1,224.00 1,069.00 54.00
2017-12-31 5,418.00 364.00 1,045.00 55.00
2017-09-30 5,395.00 241.00 1,036.00 59.00
2017-06-30 5,338.00 -183.00 1,059.00 65.00
2017-03-31 5,393.00 -120.00 1,071.00 71.00
2016-12-31 5,363.00 -122.00 1,060.00 73.00
2016-09-30 5,452.00 -58.00 1,084.00 71.00
2016-06-30 5,448.00 403.00 1,056.00 74.00
2016-03-31 5,267.00 358.00 1,010.00 72.00
2015-12-31 5,405.00 509.00 1,021.00 74.00
2015-09-30 5,381.00 499.00 980.00 77.00
2015-06-30 5,562.00 557.00 1,025.00 79.00
2015-03-31 5,901.33 549.74 1,093.50 83.34
2014-12-31 6,111.00 464.00 1,142.00 87.00
2014-09-30 6,124.08 497.20 1,192.41 88.58
2014-06-30 6,009.04 396.05 1,163.30 85.50
2014-03-31 6,243.77 644.49 1,177.00 85.03
2013-12-31 6,272.00 819.00 1,176.00 83.00
2013-09-30 6,158.46 907.48 1,103.87 81.29
2013-06-30 6,475.96 1,224.69 1,107.62 79.23
2013-03-31 6,612.55 1,316.17 1,099.69 76.59
2012-12-31 6,471.43 1,300.08 1,063.10 74.10
2012-09-30 6,880.80 1,461.59 1,091.71 71.68
2012-06-30 7,016.68 1,502.82 1,111.21 73.67

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Israel Chemicals has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
  • Israel Chemicals used its assets more efficiently than the US Chemicals industry average last year based on Return on Assets.
  • Israel Chemicals has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Israel Chemicals's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Israel Chemicals has a total score of 6/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

ICL Health

 How is Israel Chemicals's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Israel Chemicals's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Israel Chemicals is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Israel Chemicals's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Israel Chemicals's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Israel Chemicals Company Filings, last reported 3 months ago.

NYSE:ICL Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 3,915.00 2,441.00 213.00
2018-09-30 3,909.00 2,392.00 187.00
2018-06-30 3,775.00 2,502.00 235.00
2018-03-31 3,875.00 3,145.00 876.00
2017-12-31 2,930.00 3,216.00 173.00
2017-09-30 2,867.00 3,459.00 195.00
2017-06-30 2,734.00 3,445.00 145.00
2017-03-31 2,681.00 3,381.00 119.00
2016-12-31 2,659.00 3,392.00 116.00
2016-09-30 2,733.00 3,630.00 207.00
2016-06-30 3,205.00 3,682.00 242.00
2016-03-31 3,214.00 3,643.00 212.00
2015-12-31 3,188.00 3,488.00 257.00
2015-09-30 3,031.00 2,961.00 293.00
2015-06-30 3,004.00 2,898.00 308.00
2015-03-31 2,914.26 2,752.50 286.41
2014-12-31 3,000.00 2,915.00 248.00
2014-09-30 3,118.37 2,907.68 279.09
2014-06-30 3,155.83 2,922.55 260.13
2014-03-31 3,207.15 2,709.93 327.95
2013-12-31 3,678.67 2,037.27 285.59
2013-09-30 3,578.17 1,978.87 407.90
2013-06-30 3,659.94 1,859.16 340.14
2013-03-31 3,522.85 1,746.80 357.76
2012-12-31 3,388.26 1,716.74 349.01
2012-09-30 3,467.19 1,991.52 587.86
2012-06-30 3,309.14 2,064.75 473.16
  • Israel Chemicals's level of debt (62.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (55.7% vs 62.3% today).
  • Debt is well covered by operating cash flow (25.4%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 7.8x coverage).
X
Financial health checks
We assess Israel Chemicals's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Israel Chemicals has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

ICL Dividends

 What is Israel Chemicals's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
3.33%
Current annual income from Israel Chemicals dividends. Estimated to be 3.66% next year.
If you bought $2,000 of Israel Chemicals shares you are expected to receive $67 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Israel Chemicals's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.4%).
  • Israel Chemicals's dividend is below the markets top 25% of dividend payers in United States of America (3.62%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NYSE:ICL Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 6 Analyst Estimates (S&P Global) See Below
United States of America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 55 Stocks 2.5%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NYSE:ICL Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2023-12-31 0.22 1.00
2022-12-31 0.20 1.00
2021-12-31 0.21 3.00
2020-12-31 0.20 3.00
2019-12-31 0.18 3.00
NYSE:ICL Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-02-06 0.182 3.365
2018-02-14 0.149 2.911
2017-02-15 0.165 3.857
2016-03-16 0.280 6.781
2015-03-22 0.257 4.729
2014-09-28 0.450 6.356
2014-09-22 0.450 5.856
2014-09-14 0.450 5.837
2014-03-23 0.450 5.333
2014-02-12 0.450 5.293
2013-03-14 0.720 7.851
2013-03-13 0.720 5.607
2012-03-28 0.820 7.009
2012-03-27 0.820 7.001
2010-03-24 0.420 2.943
2009-12-31 0.420 3.163
2009-04-20 0.800 7.093

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of Israel Chemicals's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (5.3x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.2x coverage).
X
Income/ dividend checks
We assess Israel Chemicals's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Israel Chemicals afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Israel Chemicals has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

ICL Management

 What is the CEO of Israel Chemicals's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Raviv Zoller
COMPENSATION $2,601,650
AGE 54
TENURE AS CEO 0.9 years
CEO Bio

Mr. Raviv Zoller serves as the President of Israel Chemicals Limited since 2018 and Chief Executive Officer since May 14, 2018. Mr. Zoller serves as the Chief Executive Officer of Direct Insurance at Zur Shamir Holdings Ltd. and Direct Insurance - Financial Investments Ltd. Mr. Zoller was the Chief Executive Officer at I.D.I. Insurance Company Ltd. from May 2008 to May 13, 2018. He served as the Chief Executive Officer and President of Ness Technologies Inc., from June 2001 to March 16, 2007 and also served as its Principal Financial Officer and Principal Accounting Officer. From October 1999 to May 2001, he served as the Chief Financial Officer of Ness Technologies Inc. He founded Apex-Mutavim and also served as its Partner from 1994 to 1998. From 1991 to 1999, he was a Partner at Zoller, Radiano and Co. He has been the Chairman of I.D.I Issues (2010) Ltd. since June 19, 2011. He serves as the Chairman of the Board of Directors at Artemis Investments Ltd. He served as the Chairman and Director of I.D.I. Insurance Company Ltd. He has been a Director of Mentor Graphics Development Services (Israel) Limited since July 2007. He serves as Director of The Zinman College of Physical Education and Sport Sciences at the Wingate Institute and the Ethiopian National Project. He served as Director at Alliance Tire Company (1992) Ltd. He served as a Director of Ness Technologies Inc. from August 2004 to June 12, 2007. He is a Certified Public Accountant licensed in Israel. He holds a B.A. in Economics and Accounting from Tel Aviv University, where he also holds Master’s Degree in Economics while serving as a Faculty Member.

CEO Compensation
  • Insufficient data for Raviv to compare compensation growth.
  • Raviv's remuneration is lower than average for companies of similar size in United States of America.
Management Team Tenure

Average tenure and age of the Israel Chemicals management team in years:

2.8
Average Tenure
54
Average Age
  • The tenure for the Israel Chemicals management team is about average.
Management Team

Johanan Locker

TITLE
Executive Chairman of the Board
COMPENSATION
$2M
AGE
62

Raviv Zoller

TITLE
President & CEO
COMPENSATION
$3M
AGE
54
TENURE
0.9 yrs

Kobi Altman

TITLE
Chief Financial Officer
COMPENSATION
$1M
AGE
50
TENURE
4 yrs

Charlie Weidhas

TITLE
Chief Operating Officer
COMPENSATION
$2M
AGE
59
TENURE
2.8 yrs

Limor Gruber

TITLE
Head of Investor Relations

Lilach Geva-Harel

TITLE
Senior Vice President & Global General Counsel
AGE
41
TENURE
0.3 yrs

Maya Avishai

TITLE
Head of Global External Communications

Ilana Fahima

TITLE
Executive VP of Global Human Resources
AGE
52
TENURE
0.4 yrs

Miri Mishor

TITLE
Senior Vice President of ICL Information Technology
AGE
54
TENURE
5.3 yrs

Ido Lilian

TITLE
Chief Procurement Officer
AGE
54
TENURE
5.3 yrs
Board of Directors Tenure

Average tenure and age of the Israel Chemicals board of directors in years:

2.5
Average Tenure
59
Average Age
  • The average tenure for the Israel Chemicals board of directors is less than 3 years, this suggests a new board.
Board of Directors

Johanan Locker

TITLE
Executive Chairman of the Board
COMPENSATION
$2M
AGE
62
TENURE
2.7 yrs

Avisar Paz

TITLE
Director
AGE
61
TENURE
18 yrs

Reem Aminoach

TITLE
Director
AGE
57
TENURE
2.3 yrs

Ruth Ralbag

TITLE
External Director
AGE
58
TENURE
1.3 yrs

Nadav Kaplan

TITLE
External Director
AGE
72
TENURE
0.7 yrs

Ovadia Eli

TITLE
Director
AGE
73
TENURE
7.7 yrs

Aviad Kaufman

TITLE
Director
AGE
48
TENURE
5.1 yrs

Sagi Kabla

TITLE
Director
AGE
42
TENURE
3.2 yrs

Lior Reitblatt

TITLE
Director
AGE
60
TENURE
2.3 yrs

Yoav Doppelt

TITLE
Director
AGE
49
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
X
Management checks
We assess Israel Chemicals's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Israel Chemicals has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

ICL News

Simply Wall St News

ICL Company Info

Description

Israel Chemicals Ltd. operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces Polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. The Phosphate Solutions segment produces specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and manufactures thermal phosphoric acid for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The IAS segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. The company sells its products through marketing companies, agents, and distributors. Israel Chemicals Ltd. was founded in 1968 and is headquartered in Tel Aviv, Israel.

Details
Name: Israel Chemicals Ltd.
ICL
Exchange: NYSE
Founded: 1968
₪7,005,932,115
1,280,301,148
Website: http://www.icl-group.com
Address: Israel Chemicals Ltd.
Millenium Tower,
23 Aranha Street,
Tel Aviv,
61070,
Israel
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TASE ICL Ordinary Shares The Tel-Aviv Stock Exchange IL ILS 17. Apr 1996
NYSE ICL Ordinary Shares New York Stock Exchange US USD 17. Apr 1996
Number of employees
Current staff
Staff numbers
12,125
Israel Chemicals employees.
Industry
Fertilizers and Agricultural Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/19 23:51
End of day share price update: 2019/04/18 00:00
Last estimates confirmation: 2019/04/17
Last earnings filing: 2019/02/27
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.